Findings show which age groups are seeing the biggest increases
, /PRNewswire/ — LexisNexis® Risk Solutions, a leading provider of data and analytics, released new insights on breast and colon cancer screening and diagnosis trends from 2021 to 2023. As the U.S. Preventive Services Special Task Force (USPSTF) continues to examine and lower the age recommendations for breast cancer and colorectal cancer screenings, this analysis explores how these guidelines are impacting preventive care.
Even though the USPSTF didn’t officially lower the age recommendation for breast cancer screenings from 50 to 40 until April 2024, mammograms among adults in their 40s have been trending up for the last three years. De-identified medical claims data from LexisNexis® MarketView™ show a 10.3% increase in mammograms for this age group from 2021 to 2023. Additionally, mammograms among people in their 30s saw an even bigger percent increase, with 12.5% more mammograms in 2023 than in 2021.
The data analysis also revealed an increase in breast cancer diagnoses …